EFX
38
-2
AME
42
-3
EXPE
77
-3
HPQ
49
-3
EW
34
2
VLO
26
-3
XEL
57
4
COF
54
-3
VFC
49
-3
UA
42
4
ORLY
61
-3
PVH
50
-3
FOXA
39
-5
BRK.B
43
-2
DUK
52
2
NRG
59
7
SPG
58
-5
HRL
41
2
FLR
56
-4
WDC
50
-4
EFX
38
-2
AME
42
-3
EXPE
77
-3
HPQ
49
-3
EW
34
2
VLO
26
-3
XEL
57
4
COF
54
-3
VFC
49
-3
UA
42
4
ORLY
61
-3
PVH
50
-3
FOXA
39
-5
BRK.B
43
-2
DUK
52
2
NRG
59
7
SPG
58
-5
HRL
41
2
FLR
56
-4
WDC
50
-4
Financhill
Back

Sarepta Therapeutics 10K Form

Sell
37

SRPT
Sarepta Therapeutics

Last Price:
132.04
Seasonality Move:
9.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SRPT News And Ratings

See the #1 stock for the next 7 days that we like better than SRPT

SRPT Financial Statistics

Sales & Book Value

Annual Sales: $1.24B
Cash Flow: $-14.23M
Price / Cash Flow: 0
Annual Sales: $11.30
Price / Book: 11.37

Profitability

EPS (TTM): 0.74000
Net Income (TTM): $47.3M
Gross Margin: $1.09B
Return on Equity: 5.37%
Return on Assets: 1.46%

Sarepta Therapeutics Earnings Forecast

Key Sarepta Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 28 years for SRPT is 87.91%.
  • The Selling, General & Administrative Expenses for SRPT have been equal to 38.76% of Gross Profit Margin.
  • The Research & Development expenses have been 70.57% of Revenue.
  • The Interest Expense is -4.11% of Operating Income.
  • The Net Earning history of SRPT is -43.11% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 14 years.

Sarepta Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SRPT
CUSIP: 803607
Website: sarepta.com

Debt

Debt-to-Equity Ratio: 1.14
Current Ratio: 3.9
Quick Ratio: 2.69

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 10.49

SRPT Technical Analysis vs Fundamental Analysis

Sell
37
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy or a Sell?